[Use of an oral contraceptive Femigen-Polfa by epileptic women].
D000328:Adult; D002715:Chlormadinone Acetate / Q000009:adverse effects*; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D004054:Diethylstilbestrol / Q000009:adverse effects / Q000627:therapeutic use; D004569:Electroencephalography; D004827:Epilepsy / Q000150:complications*; D004833:Epilepsy, Temporal Lobe / Q000150:complications*; D004830:Epilepsy, Tonic-Clonic / Q000150:complications*; D005260:Female; D006801:Humans; D008598:Menstruation; D008599:Menstruation Disturbances / Q000188:drug therapy; D008656:Mestranol / Q000009:adverse effects*; D011247:Pregnancy; D011275:Pregnancy, Unwanted; D012640:Seizures / Q000139:chemically induced
D003276:Contraceptives, Oral; D002715:Chlormadinone Acetate; D004054:Diethylstilbestrol; D008656:Mestranol
W sprawie stosowania doustnego preparatu antykoncepcyjnego Femigen-Polfa u kobiet c horych na padaczke.